生物标志物 生物标志物
Jin Sung Kim1, Whani Kim2, Hyun Jeong Ko2
1Sangmyung University, Seoul, Jongno-gu, Korea, Republic of (South).
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
概括
眼动分析可以使用新型指标和智能手机技术检测阿尔茨海默病 (AD) 中的粉样β (Aβ) 病理. 这为早期Aβ检测提供了一种具有成本效益的方法,有助于及时干预.
科学领域:
- 眼科和神经科学 眼科和神经科学
- 生物标志物发现发现
- 医学诊断 医学诊断 医学诊断
背景情况:
- 粉样β (Aβ) 积累是阿尔茨海默病 (AD) 的关键生物标志物,通常通过昂贵的PET扫描来检测.
- 眼动分析为Aβ检测提供了一种具有成本效益的,非侵入性的替代方案.
- 以前的眼睛追踪研究在区分Aβ+和Aβ-个体方面遇到了挑战,特别是在刺激后的数据中.
研究的目的:
- 开发和验证一种用于区分Aβ+和Aβ-个体的眼动分析方法.
- 引入新的眼动参数,自我校正时间 (SCT) 和视线不稳定性,以提高诊断准确度.
- 为了评估这些参数在移动设置中与回归中央固定 (RCF) 阶段相结合的有效性.
主要方法:
- 193名参与者 (年龄在50岁以上) 通过PET成像被分为Aβ+或Aβ-.
- 参与者使用基于智能手机的眼睛追踪应用程序执行了反冲刺任务.
- 分析包括经典特征,新的SCT和凝视不稳定度指标,以及由机器学习模型评估的RCF阶段.
主要成果:
- 在集成所有功能 (Classic + PS + RCF) 时,CatBoost模型实现了高分类性能 (AUC 0.83,灵敏度 0.85,特异性 0.82).
- 在各种特征组合中观察到AUC的显著差异,突出显示了新参数和RCF的影响.
- 这项研究证明了SCT和凝视不稳定在区分Aβ组的有效性.
结论:
- 再定义的自我校正参数 (SCT) 和凝视不稳定度指标,以及RCF阶段,提高了移动眼睛跟踪的测量精度.
- 这种方法提供了一种经济的方法来检测粉样蛋白病理,可能使得临床前AD的早期诊断.
- 这些发现支持基于智能手机的眼睛跟踪用于加快临床干预和改善AD管理.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516